Keywords: mgi, pharma, 2nd-qtr, sales, rocket, 9m, oncology-focused

MGI Pharma's 2nd-qtr sales rocket to $46.9M

Article | 26 July 2004

US oncology-focused biopharmaceutical firm MGI Pharma saw itssecond-quarter 2004 sales leap to $46.9 million from $8.5 million for the like, year-earlier period, driven ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

MGI Pharma

Go to company listing

Related Drugs

Aloxi

Palonosetron hydrochloride

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing